Table 2. Semiquantitative scores (0–3) of nailfold videocapillaroscopy (NVC) abnormalities of long covid (LC) patients without systemic sclerosis (non-SSc-LC), 
recovered COVID-19 patients that did not develop LC (RC) and healthy matched controls (CNT).
| Non-SSc-LC patients (n=62) | RC patients(n=23) | CNT(n=84) | P values (univariate) | P values (multivariate) | P values (FDR) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LCversusCNT | RCversusCNT | LCversusRC | LCversusCNT | RCversusCNT | LCversusRC | LCversusCNT | RCversusCNT | LCversusRC | ||||
| Time between COVID-19 and NVC examination (months, mean±SD) | 17±13 | 12±7 | – | – | – | – | – | – | – | |||
| NVC findings | ||||||||||||
| Mean capillary number per linear millimetre (mean±SD) | 8.8±1.5 | 9.9±0.9 | 10±1.5 | <0.01 | n.s. | <0.01 | <0.01 | – | <0.01 | <0.01 | <0.01 | <0.01 |
| Dilated capillaries (0–3) (mean±SD) | 1.3±0.7 | 1.3±0.4 | 0.7±0.7 | <0.01 | <0.01 | n.s. | <0.01 | <0.05 | – | <0.01 | – | – |
| Abnormal shapes (0–3) (mean±SD) | 0.3±0.6 | 0.2±0.4 | 0.2±0.4 | <0.05 | n.s. | n.s. | <0.05 | – | – | <0.05 | – | – |
| Microhaemorrhages (0–3) (mean±SD) | 0.5±0.6 | 0.2±0.4 | 0.01±0.1 | 0.01 | n.s. | n.s. | <0.05 | – | – | <0.05 | – | – |
| Giant capillaries (0–3) (mean±SD) | 0±0 | 0±0 | 0±0 | n.s. | n.s. | n.s. | – | – | – | n.s. | – | – |
A p- value of ≤0.05 was considered statistically significant (bold in the table). Multivariate analysis included adjustment for age, sex, smoking habit, and comorbidities. Multiple comparisons were corrected using the Benjamini-Hochberg to control the ().
Multivariate analysis included adjustment for age, sex, smoking habit, Raynaud’s phenomenon and comorbidities.
Multiple comparisons were corrected using the Benjamini-Hochberg method to control the false discovery rate (FDR).
n.s., non-significant.